Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
about
Limited Stage Follicular Lymphoma: Current Role of Radiation TherapyApproach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryRadiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 YearsIs there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-analysis.Management of localized low-grade follicular lymphomas.Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy aloneMicroRNA-148b enhances the radiosensitivity of non-Hodgkin's Lymphoma cells by promoting radiation-induced apoptosis.Radiation therapy for localized low-grade non-Hodgkin's lymphomas.Bone marrow involvement in follicular lymphoma: comparison of histology and flow cytometry as staging procedures.Initial management strategies for follicular lymphoma.Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphomaPrimary follicular lymphoma of the cervix uteri: a review.Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma.Low dose radiotherapy in indolent lymphomas, enough is enough.Economic burden of follicular non-Hodgkin's lymphoma.Nodal follicular lymphoma: the role of radiotherapy for stages I and II.Do recent reports of prolonged survival in patients with follicular lymphoma suggest that deferral of therapy is no longer justifiable?Follicular lymphoma: emerging therapeutic strategies.The important role of radiation therapy in early-stage diffuse large B-cell lymphoma: time to review the evidence once again.Treatment of the elderly patient with diffuse large B cell lymphoma.'Watch and wait' as initial management for patients with follicular lymphomas: still a viable strategy?Therapeutic approaches in patients with newly diagnosed follicular lymphoma.Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.The importance of radiotherapy on diffuse large B cell lymphoma treatment: a current review.Chemotherapy and treatment algorithms for follicular lymphoma: a look at all options.What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?Treatment of aggressive non-Hodgkin's lymphoma in adults--are we doing any better?Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.Waldeyer's ring lymphomas: a clinical study from the Comprehensive Cancer Center West population based NHL registry.Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy.Radiotherapy in stage I-III follicular non-Hodgkin lymphoma. Retrospective analysis of a series of 50 patients.Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-up.Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma.Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study.Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?To irradiate or not to irradiate--that is the question.CD38 bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B cell malignancies.High-grade non-Hodgkin's lymphoma stage I. A retrospective study of treatment, outcome and prognostic factors in 213 patients.
P2860
Q28079742-F54E3E94-0852-4BF8-8D11-87263FEFB8D3Q28088365-71F11D7B-0649-4E99-839B-94D08290BC83Q28264598-D1CF78C7-DAF4-4E95-B9E1-FE45A202F0FAQ31072157-F5A6F67E-99A9-49FA-A452-2763FFB4B1CDQ34352628-017E97DA-9956-4C7F-B433-F0EE74FF7B01Q34769661-E0036B11-4382-4CC6-956F-B8DC9BF1C28CQ36086177-418C7449-77FF-403A-8108-8EAE89E846A0Q36255899-5884AD88-A2F4-499D-AD06-1B45663F8E16Q36634610-FE139306-1E92-4905-A9B8-17F6BD2B6546Q36655216-131411BD-0347-4EDB-AB35-F7689EE5829FQ36694730-6675431C-93F0-454D-8D43-AD2D0DD2901DQ36855221-36A339F4-0CC3-46A2-8100-D2DD4FEE1EDBQ36910325-3CF7754B-DE37-4C7E-81CE-E2215EB73773Q37045646-DAE3693E-5070-4611-A361-0B69128CE667Q37321952-D06C8465-2D78-464F-B856-B49E8C0D8713Q37407963-F5BAEBFB-18F6-4A54-8842-5CB288CD88D7Q37587999-D8BDDB92-5C95-41DD-941E-8EBA0256A93CQ37721816-EA216D46-ED6A-4F20-86B0-E95C62297845Q37738494-D5663847-8E1A-4E10-BC8E-71C5F5028AC1Q37810129-307305E4-4ED1-4AEB-9C33-D610B4171FAEQ37934960-7A350E9C-11D4-49E1-AAE3-F1970EC6FD2CQ37998553-28C84295-474C-4317-832C-38BD8A16DB65Q38051428-3486A8CB-6B21-4A23-A70B-348F42EBCD49Q38267041-63B4C70E-6BE7-4B02-BAF2-A05D23E4BA92Q38510965-38124DD7-0B75-4DBE-BA13-8EA05E0AEA9EQ38565503-E43FC514-3388-4552-B609-8959CE952E41Q38594531-B35D382E-FCDB-473B-9579-0F5716185760Q40870346-717FE5B2-9712-4486-983A-765486B8340BQ41471534-6AA2967A-7F64-4D90-A949-60FBD7125AB5Q42510611-19CEB3EC-E2DF-4940-B715-DEA62DEE2EDFQ42663383-2C0A781B-1634-4478-A2C9-50842AE8A4FEQ43120906-C143A978-607E-4F98-B782-08CEEE1C9110Q44003995-603AD1A2-66BB-474A-B149-E9FC5DCDFF17Q44103052-0F6B4AFD-F08D-4BC1-81EE-CE52685A45E2Q44353403-D6CE29DA-E7F4-4BF8-B6A6-0239A7A11245Q46309065-91AA86BE-5EC3-4D1C-9ABE-4D64E004648CQ46334893-69D749FB-2744-4D2E-9715-AF21A2320E17Q46787036-49369B39-7EC6-4455-A92B-BF8CFCA6FA2AQ47329597-00557700-8BA9-4E67-9ACF-0A0C31AAE6DCQ51032020-6EC66A30-16B4-4029-ADA5-443902B07C0B
P2860
Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Clinical stage 1 non-Hodgkin's ...... rapy alone as initial therapy.
@ast
Clinical stage 1 non-Hodgkin's ...... rapy alone as initial therapy.
@en
type
label
Clinical stage 1 non-Hodgkin's ...... rapy alone as initial therapy.
@ast
Clinical stage 1 non-Hodgkin's ...... rapy alone as initial therapy.
@en
prefLabel
Clinical stage 1 non-Hodgkin's ...... rapy alone as initial therapy.
@ast
Clinical stage 1 non-Hodgkin's ...... rapy alone as initial therapy.
@en
P2093
P2860
P356
P1476
Clinical stage 1 non-Hodgkin's ...... rapy alone as initial therapy.
@en
P2093
Anderson L
MacLennan KA
Vaughan Hudson B
Vaughan Hudson G
P2860
P2888
P304
P356
10.1038/BJC.1994.213
P407
P577
1994-06-01T00:00:00Z